Performant Healthcare, Inc (PHLT)
HEALTH INFORMATION SERVICES
Last updated: Oct 21, 2025 at 5:00 PM ET
Performant Healthcare, Inc (PHLT) Financials: Revenue, Profit and Cash Flow
Performant Healthcare reported revenue of $122.98M for the fiscal year ended Dec 31, 2024, up 8.1% from the year before. That year, net income was -$9.89M with a net margin of -8.0%, operating cash flow was $6.18M and free cash flow was -$832.00K. The quarter ended Jun 30, 2025 had revenue of $37.80M and net income of $2.08M.
Revenue and Margins
The operating margin was -7.7% in the fiscal year ended Dec 2024. Over the 9 years to Dec 2024, revenue fell from $159.38M, a compound annual decline of 2.8%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2024 | $122.98M | +8.1% | 18.3% | -7.7% | -8.0% |
| Dec 2023 | $113.74M | +4.2% | 20.5% | -5.4% | -6.6% |
| Dec 2022 | $109.18M | -12.2% | 21.9% | -6.3% | -6.0% |
| Dec 2021 | $124.39M | -20.2% | 29.7% | -1.1% | -8.3% |
| Dec 2020 | $155.94M | +3.7% | 35.5% | -9.0% | -9.0% |
| Dec 2019 | $150.43M | -3.4% | 23.4% | -13.1% | -17.8% |
| Dec 2018 | $155.67M | +17.9% | 38.2% | -1.2% | -5.1% |
| Dec 2017 | $132.05M | -6.6% | 37.8% | -5.4% | -9.6% |
| Dec 2016 | $141.36M | -11.3% | 44.2% | -5.6% | -8.1% |
| Dec 2015 | $159.38M | N/A | 44.7% | 4.2% | -1.1% |
Income Statement
In the fiscal year ended Dec 2024, the net loss widened from the year before. In the quarter ended Jun 2025, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $122.98M | $113.74M | $109.18M | $124.39M | $155.94M | $150.43M | $155.67M | $132.05M | $141.36M | $159.38M |
| Cost of revenue | $100.43M | $90.45M | $85.31M | $87.44M | $100.65M | $115.19M | $96.14M | $82.19M | $78.86M | $88.08M |
| Gross profit | $22.55M | $23.30M | $23.87M | $36.95M | $55.28M | $35.24M | $59.52M | $49.86M | $62.50M | $71.30M |
| Operating income | -$9.50M | -$6.13M | -$6.90M | -$1.32M | -$13.96M | -$19.65M | -$1.80M | -$7.09M | -$7.93M | $6.71M |
| Net income | -$9.89M | -$7.52M | -$6.54M | -$10.29M | -$13.99M | -$26.82M | -$8.01M | -$12.73M | -$11.45M | -$1.79M |
| EBITDA | -$2.34M | $935.00K | $399.00K | $8.08M | -$6.96M | -$7.24M | $9.66M | $5.14M | $6.72M | $21.08M |
Quarterly
| Line item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.80M | $33.27M | $34.77M | $31.52M | $29.36M | $27.33M | $32.57M | $29.96M | $25.48M | $25.73M | $29.24M | $27.18M |
| Gross profit | $10.98M | $7.91M | $8.06M | $5.55M | $4.83M | $4.11M | $9.26M | $6.98M | $3.77M | $3.28M | $7.03M | $5.42M |
| Operating income | $2.64M | $150.00K | -$689.00K | -$2.15M | -$2.74M | -$3.92M | $1.91M | -$650.00K | -$3.60M | -$3.79M | $204.00K | -$2.31M |
| Net income | $2.08M | -$81.00K | -$498.00K | -$2.38M | -$3.00M | -$4.02M | $1.25M | -$580.00K | -$3.97M | -$4.22M | -$235.00K | -$1.46M |
Balance Sheet
As of Dec 2024, cash and equivalents exceeded long-term debt of $8.00M by $1.29M.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $101.77M | $99.03M | $118.83M | $121.98M | $126.23M | $138.87M | $137.76M | $164.44M | $185.08M | $242.54M |
| Current assets | $38.36M | $39.78M | $57.51M | $54.71M | $54.52M | $37.00M | $31.75M | $55.53M | $72.01M | $109.25M |
| Cash and equivalents | $9.29M | $7.25M | $23.38M | $17.35M | $16.04M | $3.37M | $5.46M | $21.73M | $32.98M | $71.18M |
| Total liabilities | $25.27M | $18.32M | $34.35M | $39.56M | $84.25M | $85.25M | $60.53M | $84.11M | $98.83M | $148.68M |
| Short-term debt | N/A | N/A | $983.00K | $489.00K | $59.96M | $3.32M | $2.22M | $2.03M | $9.74M | $8.00M |
| Long-term debt | $8.00M | $5.00M | $18.18M | $19.08M | $0 | $58.56M | $41.10M | $38.55M | $43.88M | $84.14M |
| Shareholder equity | $76.50M | $80.71M | $84.48M | $82.42M | $41.98M | $53.63M | $77.23M | $80.33M | $86.25M | $93.86M |
Quarterly
| Line item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $110.95M | $105.36M | $101.77M | $101.84M | $102.44M | $99.24M | $99.03M | $100.71M | $100.59M | $103.64M | $118.83M | $118.28M |
| Total liabilities | $28.72M | $27.23M | $25.27M | $26.61M | $26.57M | $21.59M | $18.32M | $22.38M | $22.68M | $22.58M | $34.35M | $34.38M |
| Cash and equivalents | $9.08M | $9.98M | $9.29M | $7.78M | $10.42M | $3.79M | $7.25M | $17.31M | $14.98M | $12.34M | $23.38M | $25.59M |
| Shareholder equity | $82.24M | $78.13M | $76.50M | $75.24M | $75.87M | $77.65M | $80.71M | $78.33M | $77.92M | $81.06M | $84.48M | $83.90M |
Cash Flow
In the fiscal year ended Dec 2024, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.18M | $3.86M | -$2.88M | $916.00K | $20.81M | -$15.42M | -$12.15M | $2.97M | $17.78M | $16.17M |
| Capital expenditures | $7.01M | $4.14M | $3.58M | $3.42M | $3.79M | $4.86M | $7.64M | $7.26M | $7.87M | $7.89M |
| Free cash flow | -$832.00K | -$283.00K | -$6.46M | -$2.50M | $17.02M | -$20.28M | -$19.79M | -$4.29M | $9.92M | $8.28M |
| Investing cash flow | -$7.01M | -$4.14M | $1.73M | -$270.00K | -$3.79M | -$4.86M | -$5.36M | -$7.26M | -$7.87M | -$6.63M |
| Financing cash flow | $2.79M | -$15.85M | $5.06M | $608.00K | -$3.72M | $18.00M | $1.30M | -$12.68M | -$40.64M | -$18.69M |
Quarterly
| Line item | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $430.00K | $2.90M | $2.78M | -$1.31M | $4.58M | $121.00K | -$1.89M | $3.48M | $4.41M | -$2.15M | -$695.00K |
| Capital expenditures | $1.30M | $1.45M | $1.27M | $1.23M | $858.00K | $3.65M | $1.19M | $617.00K | $1.43M | $909.00K | $1.39M |
| Free cash flow | -$867.00K | $1.45M | $1.52M | -$2.54M | $3.73M | -$3.53M | -$3.07M | $2.87M | $2.98M | -$3.06M | -$2.08M |
Frequently Asked Questions About PHLT
What is Performant Healthcare's annual revenue?
Performant Healthcare reported revenue of $122.98M for the fiscal year ended Dec 31, 2024.
How fast is Performant Healthcare's revenue growing?
Revenue was up 8.1% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was -0.4%.
Is Performant Healthcare profitable?
No. Performant Healthcare reported net income of -$9.89M for the fiscal year ended Dec 31, 2024, with a net margin of -8.0%.
How much free cash flow does PHLT generate?
For the fiscal year ended Dec 31, 2024, operating cash flow of $6.18M minus capital expenditures of $7.01M produced free cash flow of -$832.00K.
How much debt does Performant Healthcare have?
The balance sheet dated Dec 31, 2024 reported long-term debt of $8.00M and cash and equivalents of $9.29M.
PHLT pages: Overview, Financials